Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 1992Biochemistry

Alzheimer's disease and control brain contain soluble derivatives of the amyloid protein precursor that end within the .beta. amyloid protein region

View Full Paper
Ask AI
Bookmark
Share

Authors

JPJ. M. PasternackCase Western Reserve UniversityMPMark R. PalmertUniversity of TorontoMUM. UsiakUniversity School

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pasternack et al. (1992) studied this question.

synapsesocial.com/papers/6a91838bae2c4ed52ef13665https://doi.org/10.1021/bi00159a038
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor1990 · 1,412 citations
  2. 2The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway.1990 · 282 citations
  3. 3Secretion of the beta/A4 amyloid precursor protein. Identification of a cleavage site in cultured mammalian cells.1991 · 178 citations
  4. 4Potentially Amyloidogenic, Carboxyl-Terminal Derivatives of the Amyloid Protein Precursor1992 · 433 citations
  5. 5Alzheimer's amyloid precursor protein produced by recombinant baculovirus expression. Proteolytic processing and protease inhibitory properties.1991 · 53 citations